Effect of thioperamide on oxidative stress markers in middle cerebral artery occlusion model of focal cerebral ischemia in rats

Human and Experimental Toxicology

Volumn 27, Issue 10, 2008, Pages 761-767

  Akhtar, M ^a   Pillai, K K ^a   Vohora, D ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Histamine; MCA occlusion; Oxidative stress; Thioperamide

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOPERAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; GRIP STRENGTH; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HISTAMINE H3 ANTAGONISTS; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID PEROXIDATION; MALE; MAZE LEARNING; MIDDLE CEREBRAL ARTERY; MOTOR ACTIVITY; MUSCLE STRENGTH; OXIDATIVE STRESS; OXIDOREDUCTASES; PIPERIDINES; RATS; RATS, WISTAR; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS;

EID: 57649095651     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327108094608     Document Type: Article

References (42)

1. Ghoneim AI. Abdel-Naim AB. Khalifa AE. El-Denshary E.. Protective effects of curcumin against ischemia/reperfusion insult in rat forebrain. Pharmacol Res 2002 ; 46: 273-279.
2. Chaudhary G. Sharma U. Jagannathan NR. Gupta YK.. Evaluation of withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 2003 ; 30: 399-404.
3. Salim S. Ahmed M. Zafar KS. Ahmad AS. Islam F.. Protective effect of Nordostachys jatamansi in rat cerebral ischemia. Pharmacol Biochem Behav 2003 ; 74: 481-486.
4. Meenakshisundram T. Sharma SS.. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004 ; 74: 969-985.
5. Adachi N.. Cerebral ischemia and brain histamine. Brain Res Rev 2005 ; 50: 275-286.
6. Adachi N. Seyfried FJ. Arai T.. Blockade of central histaminergic H2 receptors aggravates ischemic neuronal damage in gebril hippocampus. Crit Care Med 2001 ; 29: 1189-1194.
7. Adachi N.. Cerebral ischemia and histamine. Nippon Yakurigaku Zasshi 2002 ; 120: 215-221.
8. Adachi N. Oishi R. Saeki K.. Changes in the metabolism of histamine and monoamies after occlusion of the middle cerebral artery in rats. J Neurochem 1991 ; 57: 61-66.
9. Adachi N. Itoh Y. Oishi R. Saeki K.. Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion. J Cereb Blood Flow Metab 1992 ; 12: 477-483.
10. Sugimoto K. Abe K. Lee TH. Sakurai E. Yanai K. Kogure K.. Histamine depletion in brain caused by treatment with (S) alfa-fluoromethylhistidine enhances ischemic damage of gebril hippocampal CA2 neurons. Brain Res 1994 ; 666: 279-283.
11. Arrang JM. Garbarg M. Lancelot JC. Lecomte JN. Pollard H. Robba M.. Highly potent and selective ligands for histamine H3 -receptors. Nature 1987 ; 327: 117-123.
12. Arrang JM. Garbarg M. Schwartz JC.. Auto inhibition of brain histamine release mediated by novel class (H3) of histamine receptors. Nature 1983 ; 302: 1-5.
13. Akhtar M. Pillai KK. Vohora D.. Effect of thioperamide on modified forced swimming test induced oxidative stress in mice. Basic Clin Pharmacol Toxicol 2005 ; 97: 218-221.
14. Longa EZ. Weinstein PR. Carlson S. Cumminis R.. Reversible middle cerebral artery occlusion without craniocetomy in rats. Stroke 1989 ; 20: 84-91.
15. Lannert H. Hoyer S.. Intracerbroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998 ; 112: 1199-1208.
16. Ali A. Ahmed FJ. Pillai KK. Vohora D.. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav 2004 ; 5: 322-328.
17. Ragozzino ME. Pal SN. Unik K. Stefani MR. Gold PE.. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. J Neurosci 1998 ; 18: 1595-1601.
18. Lowry OH. Roseburgh NJ. Farr AL. Randal RL.. Protein measurement with the folin phenol reagent. J Biol Chem 1951 ; 193: 205-215.
19. Ohkawa H. Oishi N. Yagi K.. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979 ; 95: 351-358.
20. Ellman GL.. Tissue sulfhydryl groups. Arch Biochem Biophys 1957 ; 82: 70-77.
21. Claiborne A.. Catalase activities. In: RA Greenwald., (ed), CRC handbook of methods in oxygen radical research. Boca Raton: CRC Press ; 1985. p. 283-284.
22. Habiq WH. Prast MJ. Jakoby WB.. Glutathione S- transferase. J Biol Chem 1974 ; 249: 7130-7139.
23. Mohandas J. Marshal JJ. Diggin GG. Hovath JS. Tiller DJ.. Low activities of glutatione-related enzymes a factor in the genesis of urinary bladder cancer. Cancer Res 1984 ; 44: 5086-5091.
24. Carlbeg I. Mannervik B.. Purification and characterization of the flavoenyme glutathione reductase from rat liver. J Biol Chem 1975 ; 250: 5475-5480.
25. Beauchamp C. Fridovich I.. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971 ; 44: 276-287.
26. Yavuz O. Turkozkan N. Bilghan A. Dogulu F. Aykol S.. Effect of 2-chloro adenosine on lipid peroxide level during experimental cerebral ischemia-reperfusion in gebrils. Free Radic Biol Med 1997 ; 22: 337-341.
27. Sinha K. Degaonker MN. Jagannathan NR. Gupta YK.. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 2001 ; 428: 185-192.
28. Sinha K. Chaudhary G. Gupta YK.. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002 ; 71: 655-665.
29. Gupta YK. Chaudhary G. Sinha K.. Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat. Can J Physiol Pharmacol 2002a ; 80: 210-217.
30. Gupta YK. Sinha K. Chaudhary G. Jagannathan NR.. Protective effect of adenosine against neuronal injury induced by middle cerebral artery occlusion in rats as evidenced by diffusion-weighted imaging. Pharmacol Biochem Behav 2002b ; 72: 569-574.
31. Chaudhary G. Sharma U. Jagannathan NR. Gupta YK.. Evaluation of withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 2003 ; 30: 399-404.
32. Takasago T. Peters EE. Graham DI. Masayasu H. Mecrae IM.. Neuroprotective efficacy ebselen, an antioxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral occlusion. Br J Pharmacol 1997 ; 122: 1251-1256.
33. Haley EC.. High dose tirliazad for acute stroke (RANTTASII). RANTTAS II investigators. Stroke 1998 ; 29: 1256-1257.
34. Yamaguchi T. Sano K. Takakura K. Saito I. Shinohara Y. Asano T.. Ebselen in acute ischemic stroke. A placebo-controlled, double blind clinicl trial. Stroke 1998 ; 29: 12-17.
35. Mary V. Moussaoui S. Imprato A. Stutzmann JM.. Ebselen reduces cerebral lesions and improves neurological recovery after focal cerebral ischemia-reperfusion in rats. J Cereb Blood Flow Metab 1999 ; 19: S181.
36. Lees KR. Sharma AK. Barer D. Ford GA. Kostulas V. Cheng YF.. Tolerability and pharmacokinetic of nitrone NXY-059 in patients with acute stroke. Stroke 2001 ; 32: 675-680.
37. Vender Worp HB. Kappelle LJ. Algra A. Bar PR. Orgogozo JM. Ringelstein EB.. The effect of tirilazad mesylate on infraction volume of patients with acute ischemic stroke. Neurology 2002 ; 58: 133-135.
38. Less KR. Barer D. Ford GA. Hacke W. Kostulas V. Sharma AK.. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke 2003 ; 34: 482-487.
39. Salom JB. Perez-Asensio FJ. Burguete MC. Marin N. Pitarch C. Torregrosa G.. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. Eur J Pharmacol 2004 ; 495: 55-62.
40. Toyoda K. Fujii K. Kamouchi M. Nakane H. Arihiro S. Okada Y.. Free radical scavenger, edaravone in stroke with internal carotid artery occlusion. J Neurol Sci 2004 ; 221: 11-17.
41. Yamamoto S. Tamai I. Takaoka M. Matsumura Y.. Role of histamine H3 receptors during ischemia/reperfusion in isolated rat hearts. J Cardiovasc Pharmacol 2004 ; 43: 353-357.
42. Lerouet D. Beray-Berthat V. Palmier B. Plotkine M. Margaill I.. Changes in oxidative strss, iNOS activity and neutrophil infiltration in severe transient focal cerebral ischemia in rats. Brain Res 2002 ; 958: 166-175.